Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Jubilant Pharmova Limited
JUBLPHARMA | BSE
473.10
INR-2.00
-0.42%
JUBLPHARMA | BSE
About Jubilant Pharmova Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/09/2023
As of date
08/12/2023
Close
473.10
Open
477.40
High
491.95
Low
469.35
Jubilant Pharmova Limited operates as an integrated pharmaceutical and life sciences company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products contract manufacturing of sterile injectables and non-sterile products active pharmaceutical ingredients and solid dosage formulations as well as sale of radiopharmaceuticals through a network of 48 radio pharmacies in the United States. The Contract Research & Development Services segment provides collaborative research services to pharmaceutical innovators. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune disorders. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. Jubilant Pharmova Limited was incorporated in 1978 and is based in Noida India.
View LessJUBLPHARMA | BSE
Risk
33.9%
Sharpe
0.47
Luna's Score
46/100
Recommendation
Hold
Luna says (JUBLPHARMA | BSE)
What's Working
Positive Momentum
Value Stock (Price to Book < 3)
What's not Working
Weakness based on declining price with high volume
High Current Volume and Negative 1-Day Return
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
44.7%1 month
33.9%3 months
53.3%6 months
47.6%Return
Fundamental Ratios
PE
0
Fwd. PE
0
Price to book
1.27
Debt to equity
0.68
Debt to assets
0.32
Ent. to EBITDA
11.60
Ent. to rev.
1.46
PEG
0
Other Fundamentals
EBITDA
6.47B
MarketCap
74.98B
MarketCap(USD)
898.98M
Div. yield
1.16
Op. margin
8.64
Erngs. growth
1.06K
Rev. growth
5.10
Ret. on equity
-0.89
Short ratio
0
Short perc.
0
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
83.35
Range1M
98.95
Range3M
172.65
Volumes: Market Activity
Rel. volume
3.30
Price X volume
40.99M
